Regeneron (REGN) | Stock Overview & Key Data

Regeneron Pharmaceuticals, Inc. | Large-cap | Healthcare

$529.24

1.42%

| Regeneron Stock Comparison:

Regeneron vs Vertex Regeneron vs Alnylam Regeneron vs Royalty Pharma plc Regeneron vs Insmed Regeneron vs Incyte Regeneron vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Regeneron Performance Comparison

Loading chart data...

Regeneron

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $514.98 High: $529.55

on June 13, 2025

52 Week Range

Low: $476.49 High: $1,211.20

on June 5, 2025

on August 27, 2024

All-Time High: $1,211.20 on August 26, 2024

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $57.1B

EPS i 39.32

P/E Ratio (TTM) i 13.46

Forward P/E i 11.68

P/B Ratio i 1.91

PEG Ratio i 11.68

Div. Yield i 0.33%

ROE i 15.96%

Beta i 0.307

Debt to Equity i 9.20

Financial Highlights

Profitability

Gross Margin i 84.67%

Operating Margin i 19.94%

Profit Margin i 31.94%

Returns and Earnings

Return on Assets (TTM) i 6.91%

Return on Equity (TTM) i 15.96%

EBITDA i $5.1B

Net Income (TTM) i $4.5B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Regeneron REGN	57.14B Large-cap	7.30%	-7.82%	-22.24%	-27.63%	-26.00%	-48.94%	-8.90%	-17.81%
Vertex VRTX	116.96B Large-cap	1.10%	5.43%	-9.44%	-1.79%	12.25%	-5.26%	73.12%	55.30%
Alnylam ALNY	40.16B Large-cap	2.38%	15.41%	27.40%	25.48%	31.83%	92.03%	124.66%	104.36%
Royalty Pharma plc RPRX	19.59B Large-cap	3.14%	6.15%	6.61%	40.26%	35.09%	29.42%	-11.46%	-28.90%
Insmed INSM	17.98B Large-cap	34.11%	50.25%	31.52%	37.83%	41.14%	54.46%	431.38%	241.39%
Incyte INCY	13.11B Large-cap	-1.48%	11.41%	0.06%	-1.17%	-2.56%	9.08%	-4.94%	-35.72%

Ownership & Short Interest

Insider Ownership i 1.90%

Institutional Ownership i 92.07%

Shares Short i 3M

Short Ratio i 1.81

Short % of Shares Outstanding i 2.64%

Average 10-Day Volume i 2M

Average 90-Day Volume i 2M

Regeneron Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Regeneron would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is REGN's 52-week high and low?

In the last 52 weeks, Regeneron reached a high of $1,211.20 (on August 27, 2024) and a low of $476.49 (on June 5, 2025).

What is the market cap and P/E ratio for REGN?

Curious about Regeneron's size and valuation? Its market capitalization stands at 57.14B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.46, and the forward P/E (looking ahead) is 11.68.

Does REGN pay dividends? If so, what's the yield?

Yes, Regeneron is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.33%, and the company is expected to pay out $3.52 per share over the coming year.

Who are Regeneron's main competitors or similar companies to consider before investing?

When looking at Regeneron, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	116.96B	Healthcare	Biotechnology	-5.26%	73.12%
Alnylam ALNY	40.16B	Healthcare	Biotechnology	92.03%	124.66%
Royalty Pharma plc RPRX	19.59B	Healthcare	Biotechnology	29.42%	-11.46%
Insmed INSM	17.98B	Healthcare	Biotechnology	54.46%	431.38%
Incyte INCY	13.11B	Healthcare	Biotechnology	9.08%	-4.94%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Regeneron Pharmaceuticals, Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Regeneron's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.96%, the Debt to Equity ratio from the most recent quarter is 9.20, and its Gross Profit Margin stands at 84.67%.

What is the recent revenue and earnings growth for REGN?

Looking at Regeneron's growth, its revenue over the trailing twelve months (TTM) was $14B. Compared to the same quarter last year (YoY), quarterly revenue grew by -3.70%, and quarterly earnings saw a YoY growth of 12.00%.

How much of REGN stock is held by insiders and institutions?

Wondering who owns Regeneron stock? Company insiders (like executives and directors) hold about 1.90% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.07%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.